You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Merck
Medtronic
Baxter
Colorcon

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

FORTAZ Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Fortaz, and what generic alternatives are available?

Fortaz is a drug marketed by Teligent and is included in two NDAs.

The generic ingredient in FORTAZ is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.

Drug patent expirations by year for FORTAZ
Pharmacology for FORTAZ

US Patents and Regulatory Information for FORTAZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-002 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-003 Apr 28, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-001 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-003 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-004 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-002 Apr 28, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Merck
Medtronic
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.